Showing results (61-70 of 92) with videos related to
Sort By:
Pageof 10
Toxicon : Official Journal of the International Society on Toxinology|February 8, 2020
Potency and stability of a trivalent, catalytically inactive vaccine against botulinum neurotoxin serotypes C, E and F (triCEF)Robert Webb, Patrick M Wright, Jennifer L Brown, et al.Journal of Ethnopharmacology|July 30, 2016
Utilizing Ayurvedic literature for the identification of novel phytochemical inhibitors of botulinum neurotoxin AChinni Yalamanchili, Vamshi K Manda, Amar G Chittiboyina, et al.Vaccine|November 8, 2015
Safety and immunogenicity of ricin vaccine, RVEc™, in a Phase 1 clinical trialPhillip R Pittman, Ronald B Reisler, Changhong Y Lindsey, et al.Vaccine|July 11, 2006
Multiagent vaccines vectored by Venezuelan equine encephalitis virus replicon elicits immune responses to Marburg virus and protection against anthrax and botulinum neurotoxin in miceJohn S Lee, Jennifer L Groebner, Angela G Hadjipanayis, et al.Applied and Environmental Microbiology|December 18, 2007
Differentiation of Clostridium botulinum serotype A strains by multiple-locus variable-number tandem-repeat analysisThomas E Macdonald, Charles H Helma, Lawrence O Ticknor, et al.BMC Biology|October 7, 2009
Recombination and insertion events involving the botulinum neurotoxin complex genes in Clostridium botulinum types A, B, E and F and Clostridium butyricum type E strainsKaren K Hill, Gary Xie, Brian T Foley, et al.Plos One|September 3, 2010
Extraction of BoNT/A, /B, /E, and /F with a single, high affinity monoclonal antibody for detection of botulinum neurotoxin by Endopep-MSSuzanne R Kalb, Consuelo Garcia-Rodriguez, Jianlong Lou, et al.Antimicrobial Agents and Chemotherapy|June 17, 2009
Identification and biochemical characterization of small-molecule inhibitors of Clostridium botulinum neurotoxin serotype AVirginia Roxas-Duncan, Istvan Enyedy, Vicki A Montgomery, et al.Journal of Immune Based Therapies and Vaccines|September 5, 2008
An alternative approach to combination vaccines: intradermal administration of isolated components for control of anthrax, botulism, plague and staphylococcal toxic shockGarry L Morefield, Ralph F Tammariello, Bret K Purcell, et al.Protein Expression and Purification|October 12, 2010
Purification of a recombinant heavy chain fragment C vaccine candidate against botulinum serotype C neurotoxin [rBoNTC(H(c))] expressed in Pichia pastorisMichael P Dux, Jicai Huang, Rick Barent, et al.Pageof 10